Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
10.70
-0.10 (-0.93%)
Mar 20, 2026, 4:00 PM EDT - Market closed

Beta Bionics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
31.5830.4326.5727.68
Cash & Short-Term Investments
31.5830.4326.5727.68
Cash Growth
3.76%14.55%-4.01%-
Other Current Assets
0.1---
Total Current Assets
31.6830.4326.5727.68
Total Assets
31.6830.4326.5727.68
Net Cash (Debt)
31.5830.4326.5727.68
Net Cash Growth
3.76%14.55%-4.01%-
Net Cash Per Share
0.784.785.015.54
Updated Feb 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q